The influence of triglyceride and low-density-lipoprotein target levels on microcirculation: Is there a difference?

• Published in: Heliyon
• Main Authors: Gergely Galos, Miklos Rabai, Reka Szabo, Rita Szalai, Kalman Toth, Peter Hegyi, Barbara Sandor
• Format: Article
• Language: English
• Published: Elsevier 2024-03-01
• Subjects: Hyperlipidemia; Hypertriglyceridemia; Microcirculation; Blood viscosity; Red blood cell aggregation; Red blood cell deformability
• Online Access: http://www.sciencedirect.com/science/article/pii/S2405844024039859

Background and aims: This study aimed to validate the role of high low-density lipoprotein cholesterol [LDL-C] and triglyceride [TG] treatment target levels on the microcirculation in a very high and high cardiovascular risk group. Methods: 119 patients with high or very high cardiovascular [CV] risk were included. We have registered the main co-morbidities, smoking habits, body mass index [BMI] and the lipid lowering medication. Hematocrit, whole blood viscosity [WBV] and plasma viscosity [PV], red blood cell [RBC] aggregation and deformability and fibrinogen, total cholesterol [TC], high-density lipoprotein cholesterol [HDL-C], LDL-C and TG levels were determined. Results: The investigation found significantly higher PV values in patients with non-target LDL-C, associated with higher fibrinogen level. Non-target TG was related to deteriorated microcirculatory parameters, as significantly higher RBC aggregation, lower RBC deformability, and higher WBV and PV. The main microcirculatory benefit in diabetes could be gained from target level of TG, in chronic coronary syndrome [CCS] patients it is more advantageous to reach both LDL-C and TG target. Conclusion: The results could highlight, that TG should play a role in failing microcirculation and cause potentially life-threatening complications, which would worsen the survival and quality of life of high or very high risk CV patients.